UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056364
Receipt number R000064382
Scientific Title Development of an evaluation method for success or failure of gait using a safety suspension system and clinical application
Date of disclosure of the study information 2024/12/06
Last modified on 2025/09/14 16:29:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of an evaluation method for success or failure of gait using a safety suspension system and clinical application

Acronym

Development of an evaluation method for success or failure of gait using a safety suspension system and clinical application

Scientific Title

Development of an evaluation method for success or failure of gait using a safety suspension system and clinical application

Scientific Title:Acronym

Development of an evaluation method for success or failure of gait using a safety suspension system and clinical application

Region

Japan


Condition

Condition

Healthy individuals
Patients for rehabilitation

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To Develop of an evaluation method for success or failure of gait using a safety suspension system

Basic objectives2

Others

Basic objectives -Others

Development

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Tension values obtained from sensors installed on safety suspension systems

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Walking at a comfortable speed of 20m

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Healthy individuals
1.Consent to participate in this study
2.Healthy people aged 20 to 70

Patients for rehabilitation
1.Consent to participate in this study
2.Patients aged 20 to 85
3.Patients who can walk 20 meters, but still need the assistance of a therapist due to occasional stumbling and tripping
4.Patients who understand the task and can follow instructions

Key exclusion criteria

Healthy individuals
1.history of diseases that may affect this study
2.Pregnant women and those who may be pregnant

Patients for rehabilitation
1.Patients who have difficulty understanding instructions
2.Pregnant women and those who may be pregnant
3.Patients who need to be isolated due to infectious diseases
4.Patients who are judged to be inappropriate by the researcher

Target sample size

110


Research contact person

Name of lead principal investigator

1st name Yohei
Middle name
Last name Otaka

Organization

Fujita Health University

Division name

Department of Rehabilitation Medicine, School of Medicine

Zip code

470-1192

Address

1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, Japan

TEL

0562-93-2167

Email

rehabmed@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Yohei
Middle name
Last name Kato

Organization

Fujita Health University hospital

Division name

Department of Rehabilitation

Zip code

470-1192

Address

1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, Japan

TEL

0562-93-9752

Homepage URL


Email

kato04111871@gmail.com


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee of Fujita Health University

Address

1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, Japan

Tel

0562-93-2865

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 12 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 03 Month 23 Day

Date of IRB

2023 Year 03 Month 23 Day

Anticipated trial start date

2023 Year 03 Month 23 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

October 2, 2022: First Edition Created; Implementation Permitted March 23, 2023
July 18, 2025: Second Edition Created; Implementation Permitted September 4, 2025


Management information

Registered date

2024 Year 12 Month 05 Day

Last modified on

2025 Year 09 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064382